functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS<br />
48. Humbert P. Russell S, Richardson H. Dig,<br />
Scribble <strong>and</strong> Lgl in cell polarity, cell proliferation<br />
<strong>and</strong> cancer. Bioessays. 2003;25:542-553.<br />
49. Wakabayashi M. Interaction of Ip-dlg/KIAA0583,<br />
a membrane-associated guanylate kinase family<br />
protein, with vinexin <strong>and</strong> beta-catenin at sites of<br />
cell-cell contact. J. Biol Chem.<br />
2003;278:21709-21714.<br />
50. Mitsushima M, Sezaki T, Akahane R, Ueda K,<br />
Suetsugu S, Takenawa T, Kioka N. Protein<br />
kinase A-dependent increase in WAVE2<br />
expression induced by the focal adhesion protein<br />
vinexin. Genes to Cells. 2006;11:281-292.<br />
51. Wikipedia. Available at:<br />
http://en.wikipedia.org/wiki/Scaffold_protein.<br />
Accessed November 8, 2007.<br />
52. Burckhardt G. Wolff NA. Structure of renal<br />
organic anion <strong>and</strong> cation transporters. Am. J.<br />
Physol. Renal Physiol. 2000;278:F853-F866.<br />
53. Fisher SA, Hampe J, Onnie CM, Daly MJ,<br />
Curley C, Purcell S, S<strong>and</strong>erson J, Mansfield J,<br />
Annese V, Forbes A, Lewis CM, Schreiber S,<br />
Rioux JD, Mathew CG. Direct or indirect<br />
association in a complex disease: the role of<br />
SLC22A4 <strong>and</strong>SLC22A5 <strong>functional</strong> variants in<br />
Crohn disease. Hum. Mutat. 2006; 27: 778–<br />
785.<br />
54. Ramsay, RR. The carnitine acyltransferases:<br />
modulators of acyl-CoA-dependent reactions.<br />
Biochem. Soc. Trans. 2000; 28:182–186.<br />
55. Roediger WE, Nance S. Metabolic induction of<br />
experimental ulcerative colitis by inhibition of fatty<br />
acid oxidation. Br. J. Exp. Pathol. 1986;<br />
67:773–782.<br />
56. Tokuhiro, S. An intronic SNP in a RUNX1<br />
binding site of SLC22A4, encoding an organic<br />
cation transporter, is associated with rheumatoid<br />
arthritis. Nat. Genet. 2003;35:341-348.<br />
57. Baumgart DC, S<strong>and</strong>born WJ. Inflammatory bowel<br />
disease: clinical aspects <strong>and</strong> established <strong>and</strong><br />
evolving therapies. Lancet. 2007;369:1641-<br />
1657.<br />
58. Bamias G. Martin C, Marini M. Expression,<br />
localization <strong>and</strong> <strong>functional</strong> activity of TL1A, a<br />
novel Th1-polarizing cytokine in inflammatory<br />
bowel disease. J Immunol 2003;171:4868-<br />
4874.<br />
59. Braegger CR, Nicholls S, Murch SH. Tumour<br />
necrosis factor alpha in stool as a marker of<br />
intestinal inflammation. Lancet. 1992;339:89-<br />
91.<br />
100<br />
2012<br />
60. Lerebours E, Gower-Rousseau C, Merle V.<br />
Brazier F. Debeugny S, Marti R, Salomez JL,<br />
Hellot MF, Dupas JL, Colombel JF, Cortot A,<br />
Benichou J. Stressful life events as a risk factor<br />
for inflammatory bowel disease onset: A<br />
population-based case-control study. Am J.<br />
Gastroenterol. 2007;102:122-131.<br />
61. Hoffbr<strong>and</strong> AV, Stewart JS, Booth CC. Folate<br />
deficiency in Crohn's disease: Incidence,<br />
pathogenesis, <strong>and</strong> treatment. BMJ. 1968; 2:71-<br />
75.<br />
62. Riley SA, Mani V, Goodman MJ, et al:<br />
Comparison of delayed-release 5-ASA <strong>and</strong><br />
sulfasalazine as maintenance treatment for<br />
patients with ulcerative colitis.<br />
Gastroenterol.1988;94:1383-1389.<br />
63. Singleton JW. Law DH, Kelley ML. National<br />
Cooperative Crohn's Disease Study: Adverse<br />
reactions to drugs. Gastroenterol. 1970;77:870.<br />
64. Ferguson LR, Shelling AN, Lauren D, Heyes JA,<br />
McNabb WC. Editorial: Nutri<strong>genomics</strong> <strong>and</strong> gut<br />
health. Mut Res. 2007;622:1-6.<br />
65. Han, PD, Burke A, Baldassano RN, Rombeau<br />
JL, Lichtenstein GR. Nutrition <strong>and</strong> Inflammatory<br />
Bowel Disease. Gastroenterol. Clinics of No.<br />
America. 1999;28:423-443.<br />
66. O’Sullivan M. O’Morain C. Nutrition in<br />
inflammatory bowel disease. Clinical<br />
Gastroenterol. 2006;20:561-573.<br />
67. Hodges, LS. Medical Nutrition Therapy for GI<br />
Disorders. In: Christie, C. editor. Manual of<br />
Medical Nutrition Therapy. Florida Dietetic<br />
<strong>Association</strong>.2005. pg K2.1-K4.6<br />
68. Genova Diagnostics. Available at:<br />
http://www.gdx.net/home/. Accessed: November<br />
10, 2007.<br />
69. Oriishi T, Sata M, Toyonaga A, Sasaki E,<br />
Tanifawa K. Evalution of intestinal permeability in<br />
patients with inflammatory bowel disease using<br />
lactulose <strong>and</strong> measuring antibodies to lipid A.<br />
Gut. 1995;36:891-896.<br />
70. Teahon K RA, Foster R, Bjarnason I. Faecal<br />
calprotectin: a simple sensitive quantitative<br />
measure of intestinal inflammation in man<br />
[abstract].Gastroenterol.1997;112(suppl):A1103.<br />
71. Tibble JA, Sigthorsson G, Bjarnason I. High<br />
prevalence of NSAID enteropathy as shown by a<br />
simple faecal test. Gut. 1999;45:362-366.<br />
72. Rath HC, Caesar I, Roth M, Scholmerich J.<br />
Nutritional deficiencies <strong>and</strong> complications in
Change language